Accretion Nutraveda IPO Allotment Chances
The allotment result is out. Chances below use the final subscription figures, recorded 11:41 pm, 02 Mar IST.
The Accretion Nutraveda allotment result is out — check whether you got shares.
Check Accretion Nutraveda allotment status
Accretion Nutraveda IPO
Listed SMEPrice Band
₹122–129
Minimum application
2,000 shares (2 lots)
Total Subscription
1.91x
Allotment date
02 Feb 2026
Allotment Chances — Accretion Nutraveda IPO
Retail
52.1%
(2.19x subscribed)
High chance
S-HNI (₹2–10L)
42.9%
(2.33x subscribed)
Moderate chance
B-HNI (>₹10L)
100.0%
(2.47x subscribed)
High chance
about 5 in 10 retail applicants are likely to get allotment.
Estimate from subscription data; the registrar's draw decides.
Applications vs Allotment Slots — Accretion Nutraveda IPO
Accretion Nutraveda reserved 6,40,000 shares for retail (individual) investors. Each winner gets 2,000 shares (2 lots), so there are 320 retail slots.
Accretion Nutraveda Allotment Chances FAQs
With retail subscribed 2.19x, about 52.1% of retail applicants (about 5 in 10) are likely to be allotted 2,000 shares (2 lots). S-HNI 2.33x, about 42.9%; B-HNI 2.47x, about 100.0%.
Accretion Nutraveda reserved 6,40,000 shares for retail investors and each winner gets 2,000 shares (2 lots), so at most 320 retail applicants can be allotted.
No. Oversubscribed retail and NII categories are allotted by draw of lots, and each retail winner receives the minimum application of 2,000 shares (2 lots) (₹2,58,000 at the upper price). Separate applications from family members, each with their own PAN, are what add entries to the draw.
The Accretion Nutraveda allotment was finalised on 02 Feb 2026, with listing on 04 Feb 2026. Check the result with your PAN on the Accretion Nutraveda allotment status page.
Accretion Nutraveda IPO details · Accretion Nutraveda allotment status · how allotment chances are worked out · chances for every open IPO